First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer

NCT05648006 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Strategy adjustment

Conditions

Advanced Colorectal Carcinoma

Interventions

BIOLOGICAL: OH2
DRUG: Capecitabine
DRUG: Bevacizumab

Sponsor

Binhui Biopharmaceutical Co., Ltd.